View Single Post
Old 05-08-2007, 06:05 AM   #6
Becky
Senior Member
 
Becky's Avatar
 
Join Date: Sep 2005
Location: Stockton, NJ
Posts: 4,179
Both are very good regimens. Almost 3 years ago one did not have a choice. The standard of care was AC followed by Taxol (then if Her 2 - with Herceptin added). However, last year's ASCO (june, 2006) showed that TCH was just as good as AC followed by TH in preventing recurrence AND - it had reduced heart toxicity AND reduced the rare side effect occurence of secondary leukemia (most like due to Adriamycin).


So - especially for stage 1, TCH may be the wave of the future because of effectiveness plus it is well documented that a taxane (ie: Taxol, Taxotere, Abraxane) greatly improves lack of recurrence and disease free survival in Her2+ women (regardless of hormone status).

Hope this helps.
__________________
Kind regards

Becky

Found lump via BSE
Diagnosed 8/04 at age 45
1.9cm tumor, ER+PR-, Her2 3+(rt side)
2 micromets to sentinel node
Stage 2A
left 3mm DCIS - low grade ER+PR+Her2 neg
lumpectomies 9/7/04
4DD AC followed by 4 DD taxol
Used Leukine instead of Neulasta
35 rads on right side only
4/05 started Tamoxifen
Started Herceptin 4 months after last Taxol due to
trial results and 2005 ASCO meeting & recommendations
Oophorectomy 8/05
Started Arimidex 9/05
Finished Herceptin (16 months) 9/06
Arimidex Only
Prolia every 6 months for osteopenia

NED 18 years!

Said Christopher Robin to Pooh: "You must remember this: You're braver than you believe and stronger than you seem and smarter than you think"
Becky is offline   Reply With Quote